Diagnostic vendors — instrument placement and assay adoption
For diagnostic manufacturers whose primary products are laboratory instruments, assays or point-of-care tests, specialty sales and clinical-support organisations reach laboratories
Intelligence / Healthtech & medtech market map / Distribution, channel and commercial infrastructure / Specialty sales and clinical support organisations
Dedicated field sales, contract sales and clinical-support personnel that reach specialised clinical buyers and support product adoption.
Split by customer type.
For diagnostic manufacturers whose primary products are laboratory instruments, assays or point-of-care tests, specialty sales and clinical-support organisations reach laboratories
For software vendors whose primary products are clinical, diagnostic or medical-device workflow applications, specialty sales and clinical-support organisations reach provider acco
For life-science vendors whose primary products are research instruments, reagents, consumables or laboratory tools, specialty sales and clinical-support organisations reach labora
For medical-device manufacturers whose primary products are capital equipment and procedure-linked consumables, specialty sales and clinical-support organisations open hospital and
$25.9B ($25.9B–$25.9B) · 2025 · Bottom-up
Allocation of 50% of the USD 51,700M digital medtech distribution revenue pool to specialty sales and clinical-support organisations: 51,700 x 50% = USD 25,850M. The 50% share is a stated modelling assumption reflecting the commercial and technical support embedded in medtech distribution, not a published source figure. Forecast applies the source CAGR of 12.6%. Low confidence because no source quantifies revenue for this channel.
// Sell into Specialty sales and clinical support organisations